You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Late-Stage HCC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)

Recruiting
  • Malignant Tumor
  • Oncolytic Virus SDJ001
  • Oncolytic Virus YD06-1
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 6, 2023

GAMAD for Early-stage HCC Based on Circulating Tumor DNA

Not yet recruiting
  • Hepatocellular Carcinoma
  • GAMAD
  • (no location specified)
Nov 22, 2022

Hepatectomy for Early-stage HCC Patients With CSPH

Completed
  • HCC
  • Portal Hypertension
  • hepatectomy
  • (no location specified)
May 30, 2022

AIDS Trial in Beijing, Shenzhen, Shijiazhuang (mesenchymal stem cell, saline)

Not yet recruiting
  • AIDS
  • mesenchymal stem cell
  • saline
  • Beijing, China
  • +3 more
Jul 2, 2023

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial

Not yet recruiting
  • Hepatocellular Carcinoma
  • BCLC Stage B Hepatocellular Carcinoma
  • Atezolizumab Injection
  • +2 more
  • (no location specified)
Mar 16, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan, United States (IA therapy of HCC with CSR02-Fab-TF)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • IA therapy of HCC with CSR02-Fab-TF
  • Saint Louis, Missouri
  • +6 more
Aug 16, 2022

Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis Trial in United States (GALAD, Liver Ultrasound with or without AFP)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • +3 more
  • GALAD
  • Liver Ultrasound with or without AFP
  • Los Angeles, California
  • +9 more
Oct 18, 2023

NSCLC Trial in Guangzhou (PEF, Anti-PD-1 mAb)

Recruiting
  • NSCLC
  • PEF
  • Anti-PD-1 monoclonal antibody
  • Guangzhou, Guangdong, China
    The first Affiliated Hospital of Guangzhou Medical University
Aug 3, 2023

Cancer of Lung, Kidney or Liver Trial in Sha Tin, Nijmegen, Salamanca (Pulsed electric field treatment using the Aliya system)

Recruiting
  • Cancer of Lung, Kidney or Liver
  • Pulsed electric field treatment using the Aliya system
  • Sha Tin, Hong Kong
  • +2 more
Jun 16, 2022

Advanced Lung Non-Small Cell Carcinoma Trial (Tai-Chi intervention, Aerobic exercise intervention)

Not yet recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • Tai-Chi intervention
  • Aerobic exercise intervention
  • (no location specified)
Mar 9, 2023

Circulating Tumor DNA-Guided Late-Line Treatment in Late-Stage

Completed
  • Metastatic Breast Cancer
  • +2 more
  • Control group
  • Case group
  • (no location specified)
Jun 16, 2022

HCC Trial in China (DEB-TACE and HAIC, DEB-TACE)

Recruiting
  • HCC
  • DEB-TACE and HAIC
  • DEB-TACE
  • Luohe, Henan, China
  • +15 more
Mar 28, 2023

Hepatocellular Carcinoma Trial (PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab
  • TACE
  • Nanjing, China
  • +1 more
Dec 28, 2022

Hepatocellular Carcinoma Trial (PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab
  • TACE
  • Nanjing, China
  • +1 more
Dec 28, 2022

Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou (Bevacizumab Biosimilar QL 1101)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Bevacizumab Biosimilar QL 1101
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 20, 2023

Circulating Tumor DNA (ctDNA) in Late-stage Breast Cancer

Completed
  • Metastatic Breast Cancer
  • +2 more
  • ctDNA testing
  • (no location specified)
Jun 16, 2022

Pregnancy Related Trial in Cairo (Epidural Anesthesia, Spinal Analgesia)

Active, not recruiting
  • Pregnancy Related
  • Epidural Anesthesia
  • Spinal Analgesia
  • Cairo, Egypt
    Ain Shams University Hospitals
Jul 7, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
  • Atezolizumab plus bevacizumab
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 7, 2023

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Mar 28, 2022

Hepatocellular Carcinoma Resectable Trial in Fuzhou (neoadjuvant therapy)

Not yet recruiting
  • Hepatocellular Carcinoma Resectable
  • neoadjuvant therapy
  • Fuzhou, Fujian, China
    The First Affiliated Hospital of Fujian Medical University
Aug 19, 2023

Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,

Active, not recruiting
  • Radiomics
  • +4 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Sin-Bev-TACE, Len-TACE)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Aug 2, 2023

Hepatocellular Carcinoma Trial (Hepatectomy Combined With Camrelizumab and Apatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Hepatectomy Combined With Camrelizumab and Apatinib
  • Nanning, China
    Guangxi Medical University Cancer Hospital
Sep 4, 2022

Chronic Radiation Injury Trial (Parks surgery, PE-Bacon surgery)

Not yet recruiting
  • Chronic Radiation Injury
  • Parks surgery
  • PE-Bacon surgery
  • (no location specified)
Nov 2, 2022